Carbidopa + Levodopa + Entacapone
Average across 18 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | generic | 24 | SUPPLYING |
| Macleods Pharmaceuticals Limited | generic | 12 | SUPPLYING |
| Sandoz Inc | generic | 6 | SUPPLYING |
| Rising Pharma Holdings, Inc. | generic | 6 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg). — Recalling firm: Rising Pharma Holding, Inc. — Distributed Nationwide in the USA
